BidaskClub upgraded shares of Healthequity (NASDAQ:HQY) from a buy rating to a strong-buy rating in a research note issued to investors on Thursday morning.
Several other equities research analysts have also commented on HQY. Raymond James boosted their price target on shares of Healthequity from $85.00 to $105.00 and gave the stock an outperform rating in a report on Monday, September 10th. Bank of America lowered shares of Healthequity from a buy rating to a neutral rating and boosted their price target for the stock from $84.00 to $105.00 in a report on Thursday, September 6th. They noted that the move was a valuation call. SunTrust Banks boosted their price target on shares of Healthequity to $105.00 and gave the stock a buy rating in a report on Wednesday, September 5th. Zacks Investment Research raised shares of Healthequity from a sell rating to a hold rating in a report on Friday, July 20th. Finally, KeyCorp boosted their price target on shares of Healthequity from $82.00 to $90.00 and gave the stock a buy rating in a report on Thursday, July 19th. Four research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. The company presently has an average rating of Buy and a consensus target price of $93.08.
Shares of NASDAQ:HQY traded down $0.73 during trading on Thursday, hitting $94.01. 1,065,342 shares of the stock traded hands, compared to its average volume of 626,742. The firm has a market cap of $5.43 billion, a price-to-earnings ratio of 174.09, a price-to-earnings-growth ratio of 3.04 and a beta of 1.47. Healthequity has a 52-week low of $42.92 and a 52-week high of $99.99.
Healthequity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 4th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.12. The firm had revenue of $71.10 million during the quarter, compared to analyst estimates of $69.84 million. Healthequity had a net margin of 23.81% and a return on equity of 12.58%. The business’s quarterly revenue was up 25.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.27 EPS. As a group, equities research analysts forecast that Healthequity will post 0.87 EPS for the current year.
In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of Healthequity stock in a transaction on Monday, August 20th. The shares were sold at an average price of $86.37, for a total transaction of $345,480.00. Following the sale, the vice president now owns 99,200 shares of the company’s stock, valued at approximately $8,567,904. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In the last ninety days, insiders have sold 12,000 shares of company stock worth $1,065,240. 4.00% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in HQY. Advisors Asset Management Inc. boosted its stake in Healthequity by 5,212.2% during the 2nd quarter. Advisors Asset Management Inc. now owns 72,086 shares of the company’s stock worth $160,000 after purchasing an additional 70,729 shares during the last quarter. Meeder Asset Management Inc. acquired a new position in shares of Healthequity during the 3rd quarter valued at about $172,000. Rockefeller Capital Management L.P. acquired a new position in shares of Healthequity during the 2nd quarter valued at about $179,000. Cerebellum GP LLC acquired a new position in shares of Healthequity during the 3rd quarter valued at about $185,000. Finally, Cim LLC acquired a new position in shares of Healthequity during the 2nd quarter valued at about $204,000. 96.89% of the stock is currently owned by institutional investors.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Story: Average Daily Trade Volume – What It Means In Stock Trading
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.